{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:05:03Z","timestamp":1740146703461,"version":"3.37.3"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T00:00:00Z","timestamp":1615161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011199","name":"FP7 Ideas: European Research Council","doi-asserted-by":"publisher","award":["AdG-232997 TICE"],"award-info":[{"award-number":["AdG-232997 TICE"]}],"id":[{"id":"10.13039\/100011199","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Halfdan Jacobsen og frues legat"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Objective<\/jats:title>\n<jats:p>This explorative study aimed to assess if there are any time-dependent blood gene expression changes during the first one to eight years after breast cancer diagnosis, which can be linked to the clinical outcome of the disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Material and methods<\/jats:title>\n<jats:p>A random distribution of follow-up time from breast cancer diagnosis till blood sampling was obtained by a nested, matched case-control design in the Norwegian Women and Cancer Post-genome Cohort. From 2002\u20135, women were invited to donate blood samples, regardless of any cancer diagnosis. At end of the study period in 2015, any cancer diagnoses in the 50 000 participants were obtained via linkage to the Norwegian Cancer Registry. For each breast cancer patient (n = 415), an age- and storage time-matched control was drawn. The design gave a uniform, random length of follow-up time, independent of cancer stage. Differences in blood gene expression between breast cancer cases and controls were identified using the Bioconductor R-package limma, using a moving window in time, to handle the varying time elapsed from diagnosis to blood sample.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>The number of differentially expressed genes between cases and controls were close to 2,000 in the first year after diagnosis, but fell sharply the second year. During the next years, a transient second increase was observed, but only in women with metastatic disease who later died, both compared to invasive cases that survived (p&lt;0,001) and to metastatic cases that survived (p = 0.024). Among the differentially expressed genes there was an overrepresentation of heme metabolism and T cell-related processes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This explorative analysis identified changing trajectories in the years after diagnosis, depending on clinical stage. Hypothetically, this could represent the escape of the metastatic cancer from the immune system.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0246650","type":"journal-article","created":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T18:31:11Z","timestamp":1615228271000},"page":"e0246650","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global blood gene expression profiles following a breast cancer diagnosis\u2014Clinical follow-up in the NOWAC post-genome cohort"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2539-4603","authenticated-orcid":true,"given":"Karina Standahl","family":"Olsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Christophe","family":"Thalabard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lill-Tove","family":"Rasmussen Busund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiliv","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Holden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,3,8]]},"reference":[{"key":"pone.0246650.ref001","unstructured":"NORDCAN [Internet]. 2019. Available from: http:\/\/www-dep.iarc.fr\/NORDCAN\/NO\/frame.asp."},{"issue":"28","key":"pone.0246650.ref002","article-title":"A new non-parametric method for curve group analysis of longitudinal gene expression data of breast cancer\u2014the Norwegian Women and Cancer Post-genome Cohort","volume":"16","author":"E Lund","year":"2016","journal-title":"BMC Med Res Methodology"},{"key":"pone.0246650.ref003","article-title":"Peripheral blood cells inform on the presence of breast cancer: A population-based case-control study","author":"V Dumeaux","year":"2014","journal-title":"Int J Cancer"},{"issue":"7","key":"pone.0246650.ref004","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/AGG.S130004","article-title":"Local In Time Statistics for detecting weak gene expression signals in blood\u2013illustrated for prediction of metastases in breast cancer in the NOWAC Post-genome Cohort","volume":"2017","author":"M Holden","year":"2017","journal-title":"Advances in Genomics and Genetics"},{"key":"pone.0246650.ref005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.semcancer.2018.01.007","article-title":"Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine","volume":"51","author":"B Pasculli","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"pone.0246650.ref006","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr1859","article-title":"Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study","volume":"10","author":"V Dumeaux","year":"2008","journal-title":"Breast Cancer Research"},{"issue":"2277","key":"pone.0246650.ref007","article-title":"Metastatic Breast Cancer and Pre-Diagnostic Blood Gene Expression Profiles\u2014The Norwegian Women and Cancer (NOWAC) Post-Genome Cohort","volume":"10","author":"E Holsb\u00f8","year":"2020","journal-title":"Frontiers in Oncology"},{"issue":"9","key":"pone.0246650.ref008","doi-asserted-by":"crossref","first-page":"e1005680","DOI":"10.1371\/journal.pcbi.1005680","article-title":"Interactions between the tumor and the blood systemic response of breast cancer patients","volume":"13","author":"V Dumeaux","year":"2017","journal-title":"PLoS computational biology"},{"issue":"66","key":"pone.0246650.ref009","article-title":"Heme-Derived Metabolic Signals Dictate Immune Responses","volume":"11","author":"G Canesin","year":"2020","journal-title":"Frontiers in immunology"},{"issue":"1","key":"pone.0246650.ref010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40425-017-0283-9","article-title":"The immune system in cancer metastasis: friend or foe?","volume":"5","author":"LME Janssen","year":"2017","journal-title":"J Immunother Cancer"},{"issue":"2","key":"pone.0246650.ref011","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nri3789","article-title":"Immune cell promotion of metastasis","volume":"15","author":"T Kitamura","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"6255","key":"pone.0246650.ref012","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1126\/science.aab4082","article-title":"Somatic mutation in cancer and normal cells","volume":"349","author":"I Martincorena","year":"2015","journal-title":"Science"},{"key":"pone.0246650.ref013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2147\/CLEP.S163208","article-title":"Each pregnancy linearly changes immune gene expression in the blood of healthy women compared with breast cancer patients","volume":"10","author":"E Lund","year":"2018","journal-title":"Clinical epidemiology"},{"issue":"11","key":"pone.0246650.ref014","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1158\/1055-9965.EPI-08-0519","article-title":"Systems epidemiology in cancer","volume":"17","author":"E Lund","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"pone.0246650.ref015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ije\/dym137","article-title":"Cohort profile: The Norwegian Women and Cancer Study\u2014NOWAC\u2014Kvinner og kreft","volume":"37","author":"E Lund","year":"2008","journal-title":"Int J Epidemiol"},{"journal-title":"A Standard Operating Procedure for Outlier Removal in Large Sample Epidemiological Transcriptomics Datasets BioRxiv","year":"2017","author":"H B\u00f8velstad","key":"pone.0246650.ref016"},{"issue":"2","key":"pone.0246650.ref017","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1093\/nar\/gkm1075","article-title":"Model-based variance-stabilizing transformation for Illumina microarray data","volume":"36","author":"SM Lin","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"pone.0246650.ref018","article-title":"lumiHumanIDMapping: Illumina Identifier mapping for Human","author":"P Du","year":"2016","journal-title":"R package version 1.10.1"},{"issue":"7","key":"pone.0246650.ref019","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"43","key":"pone.0246650.ref020","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"A Subramanian","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1","key":"pone.0246650.ref021","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"},{"issue":"6","key":"pone.0246650.ref022","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database Hallmark Gene Set Collection","volume":"1","author":"A Liberzon","year":"2015","journal-title":"Cell Systems"},{"key":"pone.0246650.ref023","first-page":"060012","article-title":"Fast gene set enrichment analysis","author":"G Korotkevich","year":"2019","journal-title":"bioRxiv"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246650","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,8]],"date-time":"2021-03-08T18:31:34Z","timestamp":1615228294000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0246650"}},"subtitle":[],"editor":[{"given":"Alvaro","family":"Galli","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,8]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0246650","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2021,3,8]]}}}